<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report on four women with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> who developed two types of complications after ovulation-induction therapy for primary or secondary <z:hpo ids='HP_0000789'>infertility</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Primary <z:hpo ids='HP_0000789'>infertility</z:hpo> was associated with <z:e sem="disease" ids="C0014175" disease_type="Disease or Syndrome" abbrv="">endometriosis</z:e> in one patient </plain></SENT>
<SENT sid="2" pm="."><plain>Three had previously known <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> had inactive disease at <z:hpo ids='HP_0003674'>onset</z:hpo> of ovulation-induction therapy </plain></SENT>
<SENT sid="4" pm="."><plain>Three patients developed symptoms consistent with moderate <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> flare a few weeks after the <z:hpo ids='HP_0003674'>onset</z:hpo> of ovulation-induction therapy </plain></SENT>
<SENT sid="5" pm="."><plain>One patient developed inferior vena cava and unilateral left renal vein <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>No patient became pregnant </plain></SENT>
<SENT sid="7" pm="."><plain>A high <z:chebi fb="67" ids="50114">oestrogen</z:chebi> level induced by ovulation-induction therapy may explain the occurrence of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> flare in patients with prior inactive <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> our patients had prior asymptomatic <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>One patient developed a major thrombotic event </plain></SENT>
<SENT sid="10" pm="."><plain>The presence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> increases the thrombotic risk related to ovulation-induction therapy </plain></SENT>
<SENT sid="11" pm="."><plain>We conclude that ovulation-induction therapy should be restricted to patients with long-standing inactive <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>A preventive increase of the <z:chebi fb="0" ids="50858">corticosteroid</z:chebi> dosage should be proposed in addition to <z:chebi fb="5" ids="28304">heparin</z:chebi> or antiaggregant therapy for those with prior asymptomatic <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo>, or with <z:chebi fb="5" ids="28304">heparin</z:chebi> therapy for those with prior <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo>-related events </plain></SENT>
</text></document>